Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference55 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA. 2022;72(1):7–33.
2. Mamdani H, Matosevic S, Khalid AB, Durm G, Jalal SI. Immunotherapy in lung cancer: current landscape and future directions. Front Immunol. 2022;13:823618.
3. Broderick SR. Adjuvant and neoadjuvant immunotherapy in non-small cell lung cancer. Thorac Cardiovasc Surg. 2020;30(2):215–20.
4. Brozos-Vazquez EM, Diaz-Pena R, Garcia-Gonzalez J, Leon-Mateos L, Mondelo-Macia P, Pena-Chilet M, Lopez-Lopez R. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy. Cancer Immunoly Immunother. 2021;70(5):1177–88.
5. Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345–56.